Germany
Japan
United Kingdom
China
USD 1,020.00
3 Weeks
Lenti ORF particles, SDC4 (Myc-DDK tagged) - Human syndecan 4 (SDC4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lentiviral Particles
Lenti ORF particles, AGER (Myc-DDK tagged) - Human advanced glycosylation end product-specific receptor (AGER), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LTBR (mGFP-tagged) - Human lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, XPA (mGFP-tagged) - Human xeroderma pigmentosum, complementation group A (XPA), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, CDKN2B (mGFP-tagged) - Human cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, VPS26A (Myc-DDK tagged) - Human vacuolar protein sorting 26 homolog A (S. pombe) (VPS26A), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IL32 (mGFP-tagged) - Human interleukin 32 (IL32), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AXL (mGFP-tagged) - Human AXL receptor tyrosine kinase (AXL), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FHIT (mGFP-tagged) - Human fragile histidine triad gene (FHIT), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, AKR1C1 (mGFP-tagged) - Human aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (AKR1C1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TIE1 (Myc-DDK tagged) - Human tyrosine kinase with immunoglobulin-like and EGF-like domains 1 (TIE1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, MAPKAPK2 (mGFP-tagged) - Human mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,152.00
6 Weeks
Lenti ORF particles, MTL5 (mGFP-tagged)-Human metallothionein-like 5, testis-specific (tesmin) (MTL5), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, ITPRIP (Myc-DDK tagged) - Human inositol 1,4,5-trisphosphate receptor interacting protein (ITPRIP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, EGR1 (mGFP-tagged) - Human early growth response 1 (EGR1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, VPS35 (Myc-DDK tagged) - Human vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, RARG (mGFP-tagged) - Human retinoic acid receptor, gamma (RARG), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, LILRB3 (Myc-DDK tagged) - Human leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,428.00
3 Weeks
Lenti ORF particles, BCL11B (Myc-DDK tagged) - Human B-cell CLL/lymphoma 11B (zinc finger protein) (BCL11B), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RBPMS (mGFP-tagged) - Human RNA binding protein with multiple splicing (RBPMS), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, ARPC5 (Myc-DDK tagged) - Human actin related protein 2/3 complex, subunit 5, 16kDa (ARPC5), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, LTB4R2 (Myc-DDK tagged) - Human leukotriene B4 receptor 2 (LTB4R2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TM6SF2 (mGFP-tagged) - Human transmembrane 6 superfamily member 2 (TM6SF2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PCDH10 (mGFP-tagged) - Human protocadherin 10 (PCDH10), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PGPEP1 (mGFP-tagged) - Human pyroglutamyl-peptidase I (PGPEP1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, AR (mGFP-tagged) - Human androgen receptor (AR), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, PPARA (mGFP-tagged) - Human peroxisome proliferator-activated receptor alpha (PPARA), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC3A2 (Myc-DDK tagged) - Human solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC3A2 (mGFP-tagged) - Human solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CHD2 (Myc-DDK-tagged)-Human chromodomain helicase DNA binding protein 2 (CHD2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (Myc-DDK tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (mGFP-tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, BEST2 (Myc-DDK tagged) - Human bestrophin 2 (BEST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, BTLA (Myc-DDK tagged) - Human B and T lymphocyte associated (BTLA), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, FUT2 (Myc-DDK tagged) - Human fucosyltransferase 2 (secretor status included) (FUT2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,248.00
2 Weeks
Lenti ORF particles, LRP8 (mGFP-tagged)-Human low density lipoprotein receptor-related protein 8, apolipoprotein e receptor (LRP8), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, MAP2 (mGFP-tagged) - Human microtubule-associated protein 2 (MAP2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, RTEL1 (Myc-DDK tagged) - Human regulator of telomere elongation helicase 1 (RTEL1), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, KL (mGFP-tagged) - Human klotho (KL), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TNIK (mGFP-tagged) - Human TRAF2 and NCK interacting kinase (TNIK), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, KIR3DL3 (mGFP-tagged) - Human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 (KIR3DL3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TPCN1 (mGFP-tagged) - Human two pore segment channel 1 (TPCN1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, BTNL8 (mGFP-tagged) - Human butyrophilin-like 8 (BTNL8), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IMP3 (Myc-DDK tagged) - Human IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IMP3 (mGFP-tagged) - Human IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) (IMP3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SIRT3 (mGFP-tagged) - Human sirtuin 3 (SIRT3), nuclear gene encoding mitochondrial protein, transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,296.00
5 Weeks
Lenti ORF particles, KIF2C (Myc-DDK tagged) - Human kinesin family member 2C (KIF2C), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,296.00
5 Weeks
Lenti ORF particles, KIF2C (mGFP-tagged) - Human kinesin family member 2C (KIF2C), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, STUB1 (Myc-DDK tagged) - Human STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase (STUB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, STUB1 (mGFP-tagged) - Human STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase (STUB1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Mammalian Cell Selection
- Puromycin
Filter by
Target Symbol
- H2 (75)
- CREM (62)
- VEGFA (54)
- DISC1 (52)
- MORF4L2 (48)
- HMGA1 (46)
- PDE9A (46)
- ASPH (44)
- TPM1 (42)
- BDNF (40)
- MBP (40)
- NRG1 (40)
- CTNND1 (38)
- DTNA (38)
- OPRM1 (38)
- ABI1 (36)
- FGFR2 (36)
- KCNQ2 (36)
- SYBU (36)
- TCF7L2 (36)
- NR1I3 (34)
- PROM1 (34)
- ARPP21 (30)
- ATXN3 (30)
- FGFR1 (30)
- GNAS (30)
- NREP (30)
- PARD3 (30)
- PDE4D (30)
- ABLIM2 (28)
- ADGRG2 (28)
- CAMK2B (28)
- CD46 (28)
- CEACAM1 (28)
- CELF2 (28)
- DAG1 (28)
- DMD (28)
- EDA (28)
- EIF5A (28)
- FHL1 (28)
- GPM6B (28)
- HNRNPF (28)
- MEIS2 (28)
- PDLIM5 (28)
- SEPT9 (28)
- SMOX (28)
- SYTL2 (28)
- TGIF1 (28)
- TNNT2 (28)
- BIN1 (26)
- CD1E (26)
- DMKN (26)
- IGF1 (26)
- KCNIP2 (26)
- LDB3 (26)
- MADD (26)
- MIER1 (26)
- NCALD (26)
- NRP2 (26)
- ODF2 (26)
- OXR1 (26)
- PLEKHB1 (26)
- RBFOX2 (26)
- SORBS1 (26)
- ST3GAL3 (26)
- STAU2 (26)
- STRA6 (26)
- TFDP2 (26)
- TNNT3 (26)
- APTX (25)
- CD44 (24)
- CNOT4 (24)
- DCLK1 (24)
- ENSA (24)
- FXYD3 (24)
- HNRNPD (24)
- IKBKG (24)
- ISLR2 (24)
- MEN1 (24)
- NEDD4L (24)
- NF2 (24)
- OSBPL9 (24)
- PAK3 (24)
- PCBP2 (24)
- PDE1C (24)
- PPHLN1 (24)
- PREPL (24)
- PTPN20 (24)
- RNH1 (24)
- RTN4 (24)
- SEMA6D (24)
- SERPINA1 (24)
- TCF3 (24)
- TNIK (24)
- TP63 (24)
- TRPM3 (24)
- TTC23 (24)
- ZC3H14 (24)
- ABL2 (22)
- ARHGEF7 (22)
Species
Lentivirus
Mutants
Families
- Druggable Genome (22666)
- Transmembrane (14975)
- Transcription Factors (5878)
- Secreted Protein (3854)
- Protein Kinase (1767)
- Protease (1405)
- ES Cell Differentiation/IPS (1244)
- Stem cell - Pluripotency (1040)
- GPCR (964)
- Phosphatase (622)
- Ion Channels: Other (462)
- Adult stem cells (277)
- Nuclear Hormone Receptor (254)
- Ion Channels: Potassium (250)
- Embryonic stem cells (242)
- Ion Channels: Cys-loop Receptors (146)
- P450 (146)
- Cancer stem cells (136)
- Induced pluripotent stem cells (133)
- Ion Channels: Transient receptor potential (96)
- Stem cell relevant signaling - JAK/STAT signaling pathway (84)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (76)
- Ion Channels: Glutamate Receptors (68)
- Stem cell relevant signaling - DSL/Notch pathway (54)
- Stem cell relevant signaling - Wnt Signaling pathway (52)
- Ion Channels: ATP Receptors (30)
- Ion Channels: Cyclic nucleotide gated (26)
- Ion Channels: Sodium (22)
Pathways
- Metabolic pathways (3485)
- Pathways in cancer (1296)
- MAPK signaling pathway (1028)
- Neuroactive ligand-receptor interaction (900)
- Cytokine-cytokine receptor interaction (868)
- Olfactory transduction (832)
- Regulation of actin cytoskeleton (779)
- Endocytosis (684)
- Focal adhesion (649)
- Chemokine signaling pathway (622)
- Calcium signaling pathway (609)
- Purine metabolism (587)
- Wnt signaling pathway (578)
- Huntington's disease (561)
- Neurotrophin signaling pathway (529)
- Alzheimer's disease (522)
- Ubiquitin mediated proteolysis (514)
- Jak-STAT signaling pathway (491)
- Axon guidance (478)
- Natural killer cell mediated cytotoxicity (472)
- Insulin signaling pathway (448)
- Progesterone-mediated oocyte maturation (446)
- Tight junction (445)
- Cell adhesion molecules (CAMs) (444)
- Cell cycle (444)
- Leukocyte transendothelial migration (436)
- Oocyte meiosis (412)
- T cell receptor signaling pathway (410)
- Lysosome (409)
- ErbB signaling pathway (386)
- Adherens junction (381)
- Fc gamma R-mediated phagocytosis (366)
- Prostate cancer (365)
- Toll-like receptor signaling pathway (362)
- Apoptosis (359)
- Hematopoietic cell lineage (356)
- Melanogenesis (354)
- Spliceosome (353)
- Vascular smooth muscle contraction (352)
- Oxidative phosphorylation (350)
- GnRH signaling pathway (346)
- Parkinson's disease (342)
- Dilated cardiomyopathy (340)
- Systemic lupus erythematosus (337)
- Colorectal cancer (325)
- Hypertrophic cardiomyopathy (HCM) (320)
- Pyrimidine metabolism (313)
- Pancreatic cancer (312)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (308)
- VEGF signaling pathway (307)
- Melanoma (294)
- B cell receptor signaling pathway (290)
- TGF-beta signaling pathway (284)
- Gap junction (283)
- PPAR signaling pathway (282)
- p53 signaling pathway (282)
- Chronic myeloid leukemia (280)
- Renal cell carcinoma (270)
- Small cell lung cancer (270)
- Antigen processing and presentation (264)
- Fc epsilon RI signaling pathway (260)
- Viral myocarditis (260)
- Acute myeloid leukemia (256)
- Complement and coagulation cascades (250)
- Glioma (250)
- RIG-I-like receptor signaling pathway (250)
- Adipocytokine signaling pathway (248)
- NOD-like receptor signaling pathway (245)
- Long-term potentiation (244)
- Phosphatidylinositol signaling system (241)
- Ribosome (240)
- Long-term depression (236)
- Glycerophospholipid metabolism (230)
- Epithelial cell signaling in Helicobacter pylori infection (229)
- Cardiac muscle contraction (222)
- Glycolysis / Gluconeogenesis (217)
- Endometrial cancer (216)
- Amyotrophic lateral sclerosis (ALS) (215)
- Drug metabolism - cytochrome P450 (214)
- ECM-receptor interaction (211)
- Metabolism of xenobiotics by cytochrome P450 (206)
- Pathogenic Escherichia coli infection (198)
- Non-small cell lung cancer (196)
- Vibrio cholerae infection (195)
- Basal cell carcinoma (194)
- mTOR signaling pathway (193)
- Bladder cancer (184)
- Cytosolic DNA-sensing pathway (178)
- Inositol phosphate metabolism (177)
- Drug metabolism - other enzymes (174)
- Retinol metabolism (172)
- Arginine and proline metabolism (169)
- Valine (169)
- Arachidonic acid metabolism (168)
- Hedgehog signaling pathway (168)
- Glutathione metabolism (166)
- Starch and sucrose metabolism (155)
- RNA degradation (154)
- Thyroid cancer (154)
- N-Glycan biosynthesis (152)
- Sphingolipid metabolism (146)
- Type II diabetes mellitus (146)
- Glycerolipid metabolism (143)
- Amino sugar and nucleotide sugar metabolism (142)
- Tyrosine metabolism (142)
- Fatty acid metabolism (139)
- leucine and isoleucine degradation (137)
- Autoimmune thyroid disease (134)
- Pyruvate metabolism (131)
- Lysine degradation (128)
- Cysteine and methionine metabolism (126)
- Primary immunodeficiency (126)
- Taste transduction (126)
- Proteasome (125)
- ABC transporters (123)
- Base excision repair (123)
- Nucleotide excision repair (122)
- Type I diabetes mellitus (120)
- Tryptophan metabolism (119)
- Notch signaling pathway (118)
- SNARE interactions in vesicular transport (118)
- Ether lipid metabolism (116)
- Alanine (112)
- aspartate and glutamate metabolism (112)
- Androgen and estrogen metabolism (110)
- Porphyrin and chlorophyll metabolism (110)
- Fructose and mannose metabolism (108)
- Graft-versus-host disease (108)
- Prion diseases (107)
- Aminoacyl-tRNA biosynthesis (106)
- Butanoate metabolism (103)
- Glycine (102)
- serine and threonine metabolism (102)
- Citrate cycle (TCA cycle) (100)
- Allograft rejection (96)
- Glycosphingolipid biosynthesis - lacto and neolacto series (96)
- Propanoate metabolism (95)
- Basal transcription factors (94)
- DNA replication (94)
- Galactose metabolism (92)
- Selenoamino acid metabolism (90)
- Pentose phosphate pathway (88)
- Nitrogen metabolism (86)
- Histidine metabolism (83)
- Glycosaminoglycan degradation (82)
- Homologous recombination (82)
- O-Glycan biosynthesis (82)
- Regulation of autophagy (82)
- Linoleic acid metabolism (80)
- Maturity onset diabetes of the young (78)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (76)
- Nicotinate and nicotinamide metabolism (75)
- Dorso-ventral axis formation (72)
- Mismatch repair (72)
- Phenylalanine metabolism (68)
- RNA polymerase (68)
- Asthma (66)
- Pentose and glucuronate interconversions (66)
- Heparan sulfate biosynthesis (64)
- Primary bile acid biosynthesis (64)
- beta-Alanine metabolism (63)
- Biosynthesis of unsaturated fatty acids (62)
- Keratan sulfate biosynthesis (62)
- Ascorbate and aldarate metabolism (59)
- Pantothenate and CoA biosynthesis (59)
- One carbon pool by folate (58)
- Renin-angiotensin system (58)
- Riboflavin metabolism (57)
- Chondroitin sulfate biosynthesis (56)
- Other glycan degradation (54)
- Sulfur metabolism (54)
- alpha-Linolenic acid metabolism (54)
- Steroid biosynthesis (50)
- Glycosphingolipid biosynthesis - globo series (48)
- Terpenoid backbone biosynthesis (48)
- Non-homologous end-joining (46)
- leucine and isoleucine biosynthesis (46)
- Glyoxylate and dicarboxylate metabolism (44)
- Glycosphingolipid biosynthesis - ganglio series (42)
- Cyanoamino acid metabolism (38)
- Taurine and hypotaurine metabolism (38)
- Limonene and pinene degradation (37)
- C21-Steroid hormone metabolism (36)
- Circadian rhythm - mammal (36)
- Folate biosynthesis (34)
- Caffeine metabolism (32)
- Synthesis and degradation of ketone bodies (28)
- Protein export (26)
- Thiamine metabolism (26)
- Fatty acid elongation in mitochondria (24)
- Methane metabolism (22)
- Ubiquinone and other terpenoid-quinone biosynthesis (20)
- Lipoic acid metabolism (14)
- O-Mannosyl glycan biosynthesis (14)
- Fatty acid biosynthesis (12)
- Phenylalanine (12)
- Vitamin B6 metabolism (12)
- tyrosine and tryptophan biosynthesis (12)
- Lysine biosynthesis (10)
- D-Glutamine and D-glutamate metabolism (8)
- Biotin metabolism (4)
- D-Arginine and D-ornithine metabolism (2)